GSK And Novartis To Fund Research On African Genetic Diversity
Together, both the companies have made a commitment of fund worth “2.8 million” over a period of five years.
Genomic Research Approach for Diversity and Optimizing Therapeutics
Together, both the companies have made a commitment of fund worth “2.8 million” over a period of five years.
